Longitudinally extensive transverse myelitis associated with intrathecal synthesis of oligoclonal immunoglobulin G and with vitamin B12 deficiency
https://doi.org/10.14412/2074-2711-2016-3-71-75
Abstract
The differential diagnosis of transverse myelitis (TM) is a challenging clinical problem due to a wide range of diseases, the pattern of which may include TM. Comorbidity is also a highly relevant problem in the development of inflammatory myelopathies. The described clinical case demonstrates difficulties in the nosological diagnosis in case of monophasic TM concurrent with its several probable causes. An examination of a female patient with longitudinally extensive TM and a history of two cerebral ischemic strokes also revealed the reduced levels of vitamin B12 in serum and oligoclonal IgG in cerebrospinal fluid. A CNS lesion is regarded as a possible interaction of two typical pathological processes: inflammation and thrombogenesis. In this case vitamin B12 deficiency could predispose to the initiation and maintenance of the above mechanisms. The specific features of formulation of a diagnosis in patients with such multifactorial conditions are considered.
About the Authors
V. S. Krasnov
Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia, Saint Petersburg, Russia 6-8, Lev Tolstoy St., Saint Petersburg 197022
Russian Federation
Russian Federation
A. S. Bedenko
Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia, Saint Petersburg, Russia 6-8, Lev Tolstoy St., Saint Petersburg 197022
Russian Federation
Russian Federation
N. A. Totolyan
Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia, Saint Petersburg, Russia 6-8, Lev Tolstoy St., Saint Petersburg 197022
Russian Federation
Russian Federation
A. A. Skoromets
Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia, Saint Petersburg, Russia 6-8, Lev Tolstoy St., Saint Petersburg 197022
Russian Federation
Russian Federation
References
1. Beh SC, Greenberg BM, Frohman T, et al. Transverse myelitis. Neurol Clin. 2013 Feb;31(1):79-138. doi: 10.1016/j.ncl.2012.09.008.
2. Jacob A, Weinshenker BG. An approach to the diagnosis of acute transverse myelitis. Semin Neurol. 2008 Feb;28(1):105-20. doi: 10.1055/s- 2007-1019132.
3. Masson C. Acute transverse myelopathy: inflammatory or ischemic? Presse Med. 2005 Jul 2;34(12):869-77.
4. Transverse Myelitis Consortium Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002 Aug 27;59(4):499-505.
5. Borchers AT, Gershwin ME. Transverse myelitis. Autoimmun Rev. 2012 Jan;11(3): 231-48. doi: 10.1016/j.autrev.2011.05.018. Epub 2011 May 18.
6. Calvo AC, Mane Martinez MA, Alentorn-Palau A, et al. Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series. BMC Neurol. 2013 Oct 3;13:135. doi: 10.1186/1471-2377-13-135.
7. Scott TF, Frohman EM, De Seze J, et al. Evidence-based guidline: Clinical evaluation and treatment of transverse myelitis. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2011 Dec 13;77(24): 2128-34. doi: 10.1212/WNL.0b013e31823 dc535. Epub 2011 Dec 7.
8. Grandos A, GarcТa L, Ortega C, Lopez A. Diagnostic approach to myelopathies. Rev Colomb Radiol. 2011;22(3):1-21.
9. Евдошенко ЕП, Заславский ЛГ, Лапин СВ и др. Рецидивирующий распространенный поперечный миелит, ассоциированный с антителами к аквапорину-4. Неврологический журнал. 2011;(3):34-8. [Evdoshenko EP, Zaslavskii LG, Lapin SV, et al. Common recurrent transverse myelitis, associated with antibodies to aquaporin-4. Nevrologicheskii zhurnal. 2011;(3):34-8. (In Russ.)].
10. Koudryavtseva T, Renna R, Plantone D, Mainero C. Demyelinating and thrombotic diseases of central nervous system: common pathogenic and triggering factors. Front Neurol. 2015 Mar 24;6:63. doi: 10.3389/fneur.2015.00063. eCollection 2015.
11. Maurelli M, Bergamaschi R, Candeloro E, et al. Cerebral venous thrombosis and demyelinating diseases: report of a case in a clinically isolated syndrome suggestive of multiple sclerosis onset and review of the literature. Mult Scler. 2005 Apr;11(2):242-4.
12. Al-Hashel JY, Ahmed SF, Alexander KJ, Ahmed W. Cerebral venous thrombosis in a patient with clinically isolated spinal cord syndrome. Hindwai publishing corporation. Case Rep Neurol Med. 2013;2013:364869. doi: 10.1155/2013/364869. Epub 2013 Aug 5.
13. Miller A, Korem M, Almog R, Galboiz Y. Vitamin B12, demyelination, remyelination and repair in multiple sclerosis. J Neurol Sci. 2005 Jun 15;233(1-2):93-7.
14. Sethi NK, Robilotti E, Sadan Y. Neurological manifestations of vitamin B12 deficiency. The Internet Journal of Nutrition and Wellness. 2005;2(1):1-7.
15. Senol MG, Sonmez G, Ozdag F, Saracoglu M. Reversible myelopathy with vitamin B12 deficiency. Singapore Med J. 2008 Nov;49(11):e330-2.
16. Mastronardi FG, Min W, Wang H, et al. Attenuation of experimental autoimmune encephalomyelitis and nonimmune demyelination by IFN-beta plus vitamin B12: treatment to modify notch-1/sonic hedgehog balance. J Immunol. 2004 May 15;172(10):6418-26.
Review
For citations:
Krasnov V.S., Bedenko A.S., Totolyan N.A., Skoromets A.A. Longitudinally extensive transverse myelitis associated with intrathecal synthesis of oligoclonal immunoglobulin G and with vitamin B12 deficiency. Neurology, Neuropsychiatry, Psychosomatics. 2016;8(3):71-75. (In Russ.) https://doi.org/10.14412/2074-2711-2016-3-71-75
Views: 704
Email this article 